Intra-Cellular Therapies Inc. buy Mizuho
Start price
17.02.24
/
50%
€69.30
Target price
17.02.25
€76.07
Performance (%)
76.05%
End price
18.02.25
€122.00
Summary
This prediction ended on 18.02.25 with a price of €122.00. With a performance of 76.05% the BUY prediction by Mizuho was a big success. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Mizuho for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Mizuho from $76.00 to $82.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Mizuho for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€71.00
21.06.24
21.06.24
€93.48
21.06.25
21.06.25
73.24%
22.06.25
22.06.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€90.20
22.04.25
22.04.25
74.47%
23.04.25
23.04.25

